Guru Ownership Trend
Guru Analysis for Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics, Inc. (TRVI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $20.94 M.
Top institutional holders include Andreas Halvorsen and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $31.01 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 14.7%. Conversely, Andreas Halvorsen reduced exposure by 51.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Trevi Therapeutics, Inc. (TRVI)
Major holders include Andreas Halvorsen ($28.81 M), Paul Tudor Jones ($1.38 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.62 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $31.01 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited TRVI. The total reported sell value was $31.18 M.
Yes, 0 managers opened new positions in TRVI, and 1 increased their existing holdings. The total reported buy value was $176,317.14.